Agilent Technologies’ (A) “Peer Perform” Rating Reiterated at Wolfe Research

Agilent Technologies (NYSE:A)‘s stock had its “peer perform” rating reaffirmed by stock analysts at Wolfe Research in a research note issued to investors on Tuesday,Benzinga reports.

Other analysts also recently issued reports about the company. Morgan Stanley cut their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a research report on Tuesday, March 3rd. Barclays upped their target price on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Royal Bank Of Canada assumed coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 target price for the company. UBS Group cut their target price on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday. Two investment analysts have rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Agilent Technologies presently has an average rating of “Buy” and an average price target of $162.79.

Agilent Technologies Stock Performance

Shares of NYSE A opened at $136.08 on Tuesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The stock’s fifty day moving average price is $116.42 and its two-hundred day moving average price is $128.54. Agilent Technologies has a one year low of $108.35 and a one year high of $160.27. The firm has a market cap of $38.46 billion, a price-to-earnings ratio of 27.33, a P/E/G ratio of 2.77 and a beta of 1.26.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The firm had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the prior year, the firm posted $1.31 EPS. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, equities analysts forecast that Agilent Technologies will post 5.98 EPS for the current year.

Institutional Investors Weigh In On Agilent Technologies

A number of hedge funds have recently added to or reduced their stakes in A. Ritter Alpha LP bought a new position in shares of Agilent Technologies during the 1st quarter valued at about $203,000. Summitry LLC lifted its position in Agilent Technologies by 8.1% during the first quarter. Summitry LLC now owns 673,954 shares of the medical research company’s stock valued at $76,817,000 after purchasing an additional 50,441 shares in the last quarter. Segall Bryant & Hamill LLC purchased a new position in Agilent Technologies during the first quarter valued at $9,041,000. Essential Partners LLC lifted its position in Agilent Technologies by 35.1% during the first quarter. Essential Partners LLC now owns 2,658 shares of the medical research company’s stock valued at $303,000 after purchasing an additional 690 shares in the last quarter. Finally, Groupe la Francaise lifted its position in Agilent Technologies by 15.4% during the first quarter. Groupe la Francaise now owns 39,069 shares of the medical research company’s stock valued at $4,453,000 after purchasing an additional 5,217 shares in the last quarter. Institutional investors and hedge funds own 87.41% of the company’s stock.

About Agilent Technologies

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.